AI Article Synopsis
- Idiopathic pleuroparenchymal fibroelastosis (IPPFE) is a rare lung disease characterized by increased elastic fibers in the upper lung regions, and the study explores whether LTBP-4 could serve as a blood biomarker for this condition.
- Researchers analyzed LTBP-4 levels in lung tissues and blood samples from IPPFE patients, idiopathic pulmonary fibrosis (IPF) patients, and healthy controls, finding significant differences in LTBP-4 concentrations.
- Higher serum levels of LTBP-4 were associated with poorer prognosis and may help in diagnosing IPPFE or classifying the disease's severity.
Article Abstract
Background: Idiopathic pleuroparenchymal fibroelastosis (IPPFE) is a rare idiopathic interstitial pneumonia characterized by an upper lobe-dominant interstitial increase in predominantly elastic fibers. The accumulation of cases has resulted in a refinement of the disease concept, but there are no blood biomarkers to aid in the diagnosis or prediction of a progressive phenotype among PPFE patients. Several organizers, including latent transforming growth factor-β binding protein 4 (LTBP-4), are known to be involved in elastogenesis. However, the potential of LTBP-4 as a blood biomarker for PPFE has not been investigated.
Methods: We selected cases of clinically or histologically diagnosed IPPFE (n = 20) along with idiopathic pulmonary fibrosis (IPF) patients (n = 39) and healthy controls (n = 10). We quantified the protein levels of LTBP-4 in lung tissues and serum samples.
Results: The LTBP-4 levels in lung tissue of PPFE patients were 2.16 times higher than those of IPF patients (p = 0.032). The serum concentration of LTBP-4 (pg/ml) in IPPFE was higher than that in healthy controls (1429 [154-3620] vs. 187 [56.4-490], p = 0.013). The serum concentration of LTBP-4 in IPPFE was markedly higher than that in IPF without a significant difference (1429 [154-3620] vs. 915 [491-1967], p = 0.671). In addition, a higher concentration of LTBP-4 was associated with a poor prognosis in IPPFE patients.
Conclusions: The serum concentration of LTBP-4 may aid in the diagnosis of IPPFE or the prediction of an aggressive phenotype.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.rmed.2020.106077 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Serum latent transforming growth factor-β binding protein 4 as a novel biomarker for idiopathic pleuroparenchymal fibroelastosis.
Respir Med
September 2020
Department of Respiratory Medicine, Fukuoka University Chikushi Hospital, Fukuoka, Japan. Electronic address:
Article Synopsis
- Idiopathic pleuroparenchymal fibroelastosis (IPPFE) is a rare lung disease characterized by increased elastic fibers in the upper lung regions, and the study explores whether LTBP-4 could serve as a blood biomarker for this condition.
- Researchers analyzed LTBP-4 levels in lung tissues and blood samples from IPPFE patients, idiopathic pulmonary fibrosis (IPF) patients, and healthy controls, finding significant differences in LTBP-4 concentrations.
- Higher serum levels of LTBP-4 were associated with poorer prognosis and may help in diagnosing IPPFE or classifying the disease's severity.
Increased expression of latent TGF-β-binding protein 4 affects the fibrotic process in scleroderma by TGF-β/SMAD signaling.
Lab Invest
May 2017
Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China.
Scleroderma is a fibrosis-related disorder characterized by cutaneous and internal organ fibrosis, and excessive collagen deposition in extracellular matrix (ECM) is a major cause of fibrosis. Transforming growth factor-β (TGF-β)/SMAD signaling has a central role in the pathogenesis of fibrosis by inducing abnormal collagen accumulation in ECM, and latent TGF-β-binding protein 4 (LTBP-4) affects the secretion of latent TGF-β to ECM. A previous study indicated that bleomycin (BLM) treatment increased LTBP-4 expression in lung fibroblasts of Thy-1 knockout mice with lung fibrosis, and LTBP-4 further promoted TGF-β bioavailability as well as SMAD3 phosphorylation.
View Article and Find Full Text PDFTransforming growth factor beta 1 activation, storage, and signaling pathways in idiopathic pulmonary fibrosis in dogs.
J Vet Intern Med
April 2016
Division of Companion Animal Internal Medicine, Department of Veterinary Clinical Sciences, Faculty of Veterinary Medicine, University of Liège, Liège, Belgium.
Background: The pathogenesis of idiopathic pulmonary fibrosis (IPF) in dogs is poorly understood. In human, transforming growth factor β1 (TGF-β1) is considered central in the pathogenesis.
Objectives: To investigate TGF-β1 pathway in IPF.
Downregulation of transforming growth factor β (TGFβ) and latent TGFβ binding protein (LTBP)-4 expression in late stage canine mammary tumours.
Vet J
December 2010
Department of Veterinary Pathology, Freie Universität Berlin, Berlin, Germany.
Although canine mammary tumours (CMT) are the most common malignant tumours in bitches the pathogenesis is far from understood. To analyse the role of the transforming growth factor β (TGFβ) family in the carcinogenesis of CMT, relative mRNA and protein expression of TGFβ-1, -2 and -3, TGFβ receptor (TGFβR)-1 and -3, latent TGFβ-binding protein (LTBP)-1, -3 and -4, and oestrogen receptor α in CMT were quantified. mRNA expression concentrations were measured in laser-microdissected tissue samples of mammary adenomas, carcinomas and their lymph node metastases and normalised to the non-neoplastic mammary gland of the same dog.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!